Optomed OyjOMXHEX: OPTOMED

Directed share issue without payment to implement Board remuneration

· Issued by Optomed Oyj

Summary by 6ix AI

The Board of Directors of Optomed Plc, a Finnish medical technology company that makes handheld eye cameras, resolved to issue a total of 42,614 new shares without payment to Board members. The shares pay the part of Board remuneration that the 2026 Annual General Meeting resolved to pay in company shares.

Key details

  • The share issue is based on an authorization granted by the 2026 Annual General Meeting.
  • The new shares will entitle to dividend and confer all other shareholders' rights as of their registration.
  • Following registration of the new shares, the total number of shares in Optomed Plc will be 21,495,911.

What’s still pending

  • The new shares are intended to be registered with the Finnish Trade Register on or about August 24, 2026.
  • Optomed Plc intends to apply for the new shares to be admitted to trading on the regulated market maintained by Nasdaq Helsinki Ltd on or about August 25, 2026.

6ix AI wrote this summary from the release below and checked it against the release.

Optomed Plc Stock Exchange Release 14 August 2026 at 9.30, Helsinki

Directed share issue without payment to implement Board remuneration

The Board of Directors of Optomed Plc (the "Company") has resolved on a directed share issue without payment to implement the payment of the portion of the remuneration of the Board of Directors that is in the form of shares in the Company, as resolved by the 2026 Annual General Meeting.

In the share issue, a total of  42,614 new shares in the Company will be issued without payment to the members of the Company's Board of Directors. The resolution on the share issue is based on the authorization granted by the 2026 Annual General Meeting.

The new shares are intended to be registered with the Finnish Trade Register on or about 24 August 2026 and will entitle to dividend and confer all other shareholders' rights as of their registration. The Company intends to apply for the admission of the new shares to trading on the regulated market maintained by Nasdaq Helsinki Ltd on or about 25 August 2026.

Following the registration of the new shares, the total number of shares in the Company will be 21,495,911 shares.

Optomed Plc

Further enquiries

Sakari Knuutti, CFO, Optomed Plc, sakari.knuutti@optomed.com

Optomed in Brief

Optomed is a Finnish medical technology company and one of the leading providers of handheld fundus cameras. Optomed combines handheld fundus cameras with software and artificial intelligence with the aim to transform the diagnostic process of blinding eye diseases, such as rapidly increasing diabetic retinopathy. In its business Optomed focuses on eye screening devices and software solutions related R&D in Finland and sales through different channels in over 60 countries.

www.optomed.com

https://news.cision.com/optomed-oyj/r/directed-share-issue-without-payment-to-implement-board-remuneration,c4383454

(c) 2026 Cision. All rights reserved., source Press Releases - English

Optomed Oyj on 6ix

In the deck

Earlier from Optomed

Later from Optomed

All Optomed news releases